SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-21-024418
Filing Date
2021-02-16
Accepted
2021-02-16 17:28:25
Documents
1
Group Members
HENRY A. PLAIN, JR.JEAN M. GEORGELIGHTSTONE SINGAPORE ASSOCIATES, LLCLIGHTSTONE SINGAPORE, L.P.LIGHTSTONE VENTURES (A), L.P.LSV ASSOCIATES, LLCMICHAEL A. CARUSI

Document Format Files

Seq Description Document Type Size
1 SC 13D tm216838d1_sc13d.htm SC 13D 215612
  Complete submission text file 0001104659-21-024418.txt   217470
Mailing Address 500 BOYLSTON STREET, SUITE 1380 BOSTON MA 02116
Business Address 500 BOYLSTON STREET, SUITE 1380 BOSTON MA 02116 (617) 933-3770
Lightstone Ventures, L.P. (Filed by) CIK: 0001572522 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Gemini Therapeutics, Inc. /DE (Subject) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91633 | Film No.: 21641098
SIC: 2834 Pharmaceutical Preparations